NASDAQ: NLTX       Neoleukin Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
12.18   +0.08 (0.66%)  11.31 - 12.60  562,000


Avg Volume (4 weeks):207,126
4 Weeks Range:10.67 - 14.656
4 Weeks Price Volatility (%):
52 Weeks Range:2.53 - 14.82
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Nile Therapeutics, Inc. (Nile) is a development-stage biopharmaceutical company in the business of commercially developing products for the treatment of cardiovascular diseases. The Company's product CD-NP, a chimeric natriuretic peptide is in Phase II clinical studies for the treatment of heart failure. The Company is developing CD-NP for an initial indication of acute decompensated heart failure (ADHF). The Company is also developing CU-NP, a pre-clinical rationally designed natriuretic peptide that consists of amino acid chains identical to those produced by the human body, specifically the ring structure of C-type natriuretic peptide (CNP), and the N- and C-termini of Urodilatin (URO).

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

4779  3343  551  179 

Top 10 Active Counters
 GE 6.57-0.21 
 NLY 6.16-0.18 
 SPY 304.32+1.35 
 BAC 24.12-0.74 
 ADAP 11.07+6.21 
 MRO 5.34-0.36 
 F 5.71-0.14 
 XLF 23.41-0.27 
 SQQQ 9.43-0.40 
 NERV 3.71-9.76 
Partners & Brokers